| pubmed-article:15067134 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15067134 | lifeskim:mentions | umls-concept:C0043227 | lld:lifeskim |
| pubmed-article:15067134 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:15067134 | lifeskim:mentions | umls-concept:C0002068 | lld:lifeskim |
| pubmed-article:15067134 | lifeskim:mentions | umls-concept:C0443286 | lld:lifeskim |
| pubmed-article:15067134 | lifeskim:mentions | umls-concept:C0175921 | lld:lifeskim |
| pubmed-article:15067134 | lifeskim:mentions | umls-concept:C1522538 | lld:lifeskim |
| pubmed-article:15067134 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:15067134 | lifeskim:mentions | umls-concept:C1710236 | lld:lifeskim |
| pubmed-article:15067134 | lifeskim:mentions | umls-concept:C1260969 | lld:lifeskim |
| pubmed-article:15067134 | lifeskim:mentions | umls-concept:C1563350 | lld:lifeskim |
| pubmed-article:15067134 | lifeskim:mentions | umls-concept:C1563351 | lld:lifeskim |
| pubmed-article:15067134 | lifeskim:mentions | umls-concept:C1882151 | lld:lifeskim |
| pubmed-article:15067134 | lifeskim:mentions | umls-concept:C0332514 | lld:lifeskim |
| pubmed-article:15067134 | lifeskim:mentions | umls-concept:C0598002 | lld:lifeskim |
| pubmed-article:15067134 | pubmed:issue | 15 | lld:pubmed |
| pubmed-article:15067134 | pubmed:dateCreated | 2004-4-14 | lld:pubmed |
| pubmed-article:15067134 | pubmed:abstractText | Catalyst and substrate studies have been performed on the rhodium-catalyzed asymmetric ring opening reaction. A working model is advanced that involves oxidative insertion with retention to form an organorhodium intermediate that then undergoes nucleophilic attack with inversion. Kinetic and competition experiments have uncovered evidence for a proton transfer step in the catalytic cycle that may activate both the allylrhodium intermediate and the nucleophile. We have also conducted experiments designed to understand which properties of the PPF-P(t)Bu(2) ligand contribute to the high reactivities and enantioselectivities. | lld:pubmed |
| pubmed-article:15067134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15067134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15067134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15067134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15067134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15067134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15067134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15067134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15067134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15067134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15067134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15067134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15067134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15067134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15067134 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15067134 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15067134 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
| pubmed-article:15067134 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:15067134 | pubmed:issn | 0027-8424 | lld:pubmed |
| pubmed-article:15067134 | pubmed:author | pubmed-author:LautensMarkM | lld:pubmed |
| pubmed-article:15067134 | pubmed:author | pubmed-author:FagnouKeithK | lld:pubmed |
| pubmed-article:15067134 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15067134 | pubmed:day | 13 | lld:pubmed |
| pubmed-article:15067134 | pubmed:volume | 101 | lld:pubmed |
| pubmed-article:15067134 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15067134 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15067134 | pubmed:pagination | 5455-60 | lld:pubmed |
| pubmed-article:15067134 | pubmed:dateRevised | 2010-9-20 | lld:pubmed |
| pubmed-article:15067134 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15067134 | pubmed:articleTitle | Rhodium-catalyzed asymmetric ring opening reactions of oxabicyclic alkenes: catalyst and substrate studies leading to a mechanistic working model. | lld:pubmed |
| pubmed-article:15067134 | pubmed:affiliation | Davenport Research Laboratories, Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON, Canada M5S 3H6. mlautens@alchemy.chem.utoronto.ca | lld:pubmed |
| pubmed-article:15067134 | pubmed:publicationType | Journal Article | lld:pubmed |
